#National Cancer Institute

A greater use of telemedicine has emerged as one of the positive changes that could be continued after the pandemic has passed.

NCI awards Fred Hutch $3.5M to create a colorectal cancer risk calculator based on data from multiethnic populations.

“There was a dramatic reduction [in nausea and vomiting] within 24 hours in the people who received olanzapine."

This new test could “play an important role” in screening people who are at risk for developing hepatocellular carcinoma.

The NCCAPS study will help scientists answer key questions about COVID-19’s impact on cancer patients.

The bottom-line message for breast cancer survivors is “move as often as you can, when you can.”

It was 27% more accurate than the standard approach at detecting any metastases.

NCI’s Cancer Information Service, housed at the Hutch, fills a vital gap between patient and provider, especially amid a pandemic

An early study in mice had suggested the on-again, off-again dosing strategy would help shrink tumors.

“Cancer survivors need the expertise of someone who knows cancer and understands what is ‘normal’ for a cancer survivor.”

The first clinical trial will test a therapy designed to target a protein on cancer cells in young people with acute myeloid leukemia.

This makes a big difference in preventing the more than half a million new cervical cancer cases and over 300,000 deaths globally each year.

“With BAX, we have a single target for blocking both types of cell death stemming from the use of doxorubicin."

Women who have undergone standard radiation therapy have reported pain, diarrhea and fecal incontinence.

COVID-19 has disrupted care and raised treatment safety concerns. These trustworthy sources can help you stay up to date.

People whose gut microbiome become less diverse after a transplant have a higher risk of death from any cause in the weeks after treatment.